Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 19321 - 19330 of 24215
Identification Number | Trade Name | Benefit Category |
---|---|---|
02454769 | METOJECT SUBCUTANEOUS LIQ INJ 17.5MG/0.35ML | Standard Benefit for Eligible Clients |
02454777 | METOJECT SUBCUTANEOUS LIQ INJ 22.5MG/0.45ML | Standard Benefit for Eligible Clients |
02454785 | TRANEXAMIC ACID INJ 100MG/ML | Standard Benefit for Eligible Clients |
02454807 | SANDOZ DICLOFENAC OPHTHALMIC LIQ 0.1% | Standard Benefit for Eligible Clients |
02454823 | METOJECT SUBCUTANEOUS LIQ INJ 7.5MG/0.15ML | Standard Benefit for Eligible Clients |
02454831 | METOJECT SUBCUTANEOUS LIQ INJ 10MG/0.2ML | Standard Benefit for Eligible Clients |
02454858 | METOJECT SUBCUTANEOUS LIQ INJ 15MG/0.3ML | Standard Benefit for Eligible Clients |
02454866 | METOJECT SUBCUTANEOUS LIQ INJ 20MG/0.4ML | Standard Benefit for Eligible Clients |
02454874 | METOJECT SUBCUTANEOUS LIQ INJ 25MG/0.5ML | Standard Benefit for Eligible Clients |
02455005 | BRILINTA TAB 60MG | This is not a Standard Benefit. Special Authorization is required. |
Displaying 19321 - 19330 of 24215